Healthcare

Pharmaceuticals Medical Devices Health Insurance Pharmaceutical Industry Healthcare Companies Biotechnology Insurance Medical Technology Healthcare Services Healthcare Providers

Samsung Biologics to Acquire GSK’s Human Genome Sciences Rockville Manufacturing Site for $280 Million

Closing is slated for late Q1 2026, positioning the facility to join Samsung’s global CDMO network.

Inspire Medical Investors Face Jan. 5 Lead-Plaintiff Deadline in Securities Suit Over Inspire V Rollout

Medtronic’s Diabetes Unit MiniMed Files for Nasdaq IPO

Jan. 16 Deadline Nears in Skye Bioscience Investor Class Actions

Medline Closes Upsized IPO After Soaring Debut in 2025’s Largest Listing

Trump Poised to Launch Medicare CBD Pilot as Early as 2026

GreensKeeper’s Value Fund Edges Positive for 2025 After 4% Q3 Lift

Sanofi Secures Global Rights to ADEL’s Alzheimer’s Antibody in Deal Worth Up to $1.04 Billion

Investor Lawsuits Target Inspire Medical Over Inspire V Rollout as Firms Seek Lead Plaintiff

Philips to Acquire SpectraWAVE to Boost AI Intravascular Imaging and Physiology

Cencora to Buy TPG’s Stake in OneOncology in $5 Billion Deal

Inspire Medical Investors Urged to Act as Jan. 5 Lead‑Plaintiff Deadline Nears in Inspire V Securities Case

Canopy Growth Jumps as Reports Say Trump May Pursue Federal Cannabis Rescheduling

HSBC Upgrades AbbVie to Buy, Lifts Target to $265 as Skyrizi and Rinvoq Drive Growth

Zealand Pharma Unveils ‘Metabolic Frontier 2030’ With Targets for Five Launches

CVS Lifts 2025 Outlook, Sets 2026 Targets and Unveils AI Consumer Platform

Teleflex To Divest Acute Care, Interventional Urology and OEM Units for $2.03 Billion

CMS Picks CLEAR to Modernize Medicare.gov Identity Verification Starting in 2026

FDA Meeting Minutes Undercut uniQure’s Plan to File Huntington’s Gene Therapy for Approval

Philips Reaffirms February Date for 2026 Outlook as Stock Slides on CEO Caution